Subretinal hemorrhages secondary to age-related macular degeneration: Psychological and vision-related functional perspectives

Ophthalmologica

Volumn 222, Issue 3, 2008, Pages 199-204

  Mozaffarieh, Maneli ^a   Sacu, Stefan ^a   Benesch, Thomas ^a   Wedrich, Andreas ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Age related macular degeneration; Psychological distress; Subretinal hemorrhage; Vision related functioning

Indexed keywords

ALTEPLASE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISTRESS SYNDROME; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; RETINA HEMORRHAGE; RETINA MACULA AGE RELATED DEGENERATION; VISUAL ACUITY; VISUAL IMPAIRMENT;

AGED; FEMALE; FIBRINOLYTIC AGENTS; FLUOROCARBONS; FOLLOW-UP STUDIES; HUMANS; INJECTIONS; MACULAR DEGENERATION; MALE; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RECOMBINANT PROTEINS; RETINAL HEMORRHAGE; TISSUE PLASMINOGEN ACTIVATOR; VISUAL ACUITY; VITREOUS BODY;

EID: 44349112869     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000126084     Document Type: Article

References (32)

1. Avery RL, Fekrat S, Hawkins BS, et al: Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration. Retina 1996;16:183-189.
2. Scupola A, Coscas G, Soubrane G, et al: Natural history of macular subretinal hemorrhage in age-related macular degeneration. Ophthalmologica 1999;213:97-102.
3. Bennett SR, Folk JC, Blodi CF, et al: Factors prognostic of visual outcome in patients with submacular hemorrhage. Am J Ophthalmol 1990;109:33-37.
4. Ibanez HE, Williams DF, Thomas MA, et al: Surgical removal of submacular hemorrhage: a series of 47 consecutive cases. Arch Ophthalmol 1995;113:62-69.
5. Herriot W: Intravitreal gas and TPA: an outpatient procedure for subretinal hemorrhage. Vitrectomy Meeting, Vail, October 1996.
6. Hassan AS, Johnson MW, Schneiderman TE, et al: Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology 1999;106:1900-1906.
7. Hattenbach LO, Klais C, Koch FH, et al: Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions. Ophthalmology 2001;108:1485-1492.
8. Hay SR, Madonna RJ: Intravitreal injection of tissue plasminogen activator and gas bubble for treatment of subretinal hemorrhage in ARMD. Optometry 2000;71:715-721.
9. Hesse L, Schmidt J, Kroll P: Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas. Graefes Arch Clin Exp Ophthalmol 1999;237:273-277.
10. Leguay J, Gastaud P: Subretinal hematoma in age-related macular degeneration: treatment with intravitreal injection of tPA and gas. J Fr Ophtalmol 2000;23:797-801.
11. Schulze SD, Hesse L: Tissue plasminogen activator plus gas injection in patients with subretinal hemorrhage caused by age-related macular degeneration: predictive variables for visual outcome. Graefes Arch Clin Exp Ophthalmol 2002;240:717-720.
12. Stein JD, Brown MM, Brown GC, et al: Quality of life with macular degeneration: perceptions of patients, clinicians, and community members. Br J Ophthalmol 2003;87:8-12.
13. Rovner BW, Casten RJ, Hegel MT, et al: Dissatisfaction with performance of valued activities predicts depression in age-related macular degeneration. Int J Geriatr Psychiatry 2007;22:789-793.
14. Rovner BW, Casten RJ, Hegel MT, et al: Minimal depression and vision function in age-related macular degeneration. Ophthalmology 2006;113:1743-1747.
15. Brody BL, Gamst AC, Williams RA, et al: Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology 2001;108:1893-1900, discussion 1900-1901.
16. Hazel CA, Petre KL, Armstrong RA, et al: Visual function and subjective quality of life compared in subjects with acquired macular disease. Invest Ophthalmol Vis Sci 2000;41:1309-1315.
17. Riusala A, Sarna S, Immonen I: Visual function index (VF-14) in exudative age-related macular degeneration of long duration. Am J Ophthalmol 2003;135:206-212.
18. Goldberg D: Manual of the General Health Questionnaire. Windsor, NFER Publishing, 1979.
19. Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370.
20. Herrmann C: International experiences with the Hospital Anxiety and Depression Scale - a review of validation data and clinical results. J Psychosom Res 1997;42:17-41.
21. Campbell A, Converse PE, Rodgers WL: The Quality of American Life. New York, Russel Sage Foundation, 1976.
22. Riesenberg D, Glass RM: The Medical Outcomes Study. JAMA 1989;262:943.
23. Cassel EJ: The nature of suffering and the goals of medicine. N Engl J Med 1982;306:639-645.
24. Adams GL, Pearlman JT, Sloan SH: Guidelines for the psychiatric referral of visually handicapped patients. Ann Ophthalmol 1971;3:72-81.
25. Brown MM, Brown GC, Sharma S, et al: The burden of age-related macular degeneration: a value-based analysis. Curr Opin Ophthalmol 2006;17:257-266.
26. Hassell JB, Lamoureux EL, Keeffe JE: Impact of age related macular degeneration on quality of life. Br J Ophthalmol 2006;90:593-596.
27. Hogg RE, Chakravarthy U: Visual function and dysfunction in early and late age-related maculopathy. Prog Retin Eye Res 2006;25:249-276.
28. Tasman W, Rovner B: Age-related macular degeneration: treating the whole patient. Can J Ophthalmol 2005;40:389-391.
29. Chakravarthy U, Stevenson M: Self-reported visual functioning and quality of life in age-related macular degeneration. Curr Opin Ophthalmol 2005;16:179-183.
30. Mozaffarieh M, Heinzl H, Sacu S, et al: Inpatient management and treatment satisfaction after intravitreous plasminogen activator injection. Graefes Arch Clin Exp Ophthalmol 2006;244:1421-1428.
31. Schmidt JC, Meyer CH, Horle S: Massive subretinal hemorrhages: a challenge for vitreous body surgeons. Ophthalmologe 2004;101:584-588.
32. de Juan E Jr, Machemer R: Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration. Am J Ophthalmol 1988;105:25-29.